Neuroprotective effect of recombinant adeno‑associated virus human thioredoxin‑PR39 on acute cerebral infarction in rats
Authors:
- 17 July 2018
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 16 (3) , 2633-2638
Abstract
The recombinant adeno‑associated virus human thioredoxin‑PR39 (rAAV/hTRX‑PR39) has been demonstrated to have a protective effect on hypoxic cells. The present study aimed to explore the potential effect of rAAV/hTRX‑PR39 on acute cerebral infarction in rats. Middle cerebral artery occlusion (MCAO) model rats were produced and divided into three groups: Normal saline group, empty virus group (rAAV, without hTRX‑PR39 cDNA) and rAAV/hTRX‑PR39 group. Hematoxylin and eosin staining and electron microscopy observation were used to assess the morphological changes of ischemic brain tissue during different periods. Immunohistochemistry was employed to detect the expression of CD34 to reflect angiogenesis of ischemic brain tissue. Rats treated with rAAV/hTRX‑PR39 showed an alleviated degree of ischemic brain edema relative to that in control groups, suggesting PR39 can ameliorate brain damage after cerebral ischemia. In the rAAV/hTRX‑PR39 group, CD34‑positive cells were significantly increased in ischemic brain tissues compared to control groups. Furthermore, CD34‑positive cells were primarily observed around the perivascular in ischemic brain, indicating the angiogenesis role of PR39 in ischemic brain. The present findings suggest that PR39 could effectively ameliorate ischemic brain damage and promote angiogenesis, which may contribute to the treatment of acute cerebral infarction.Keywords
This publication has 28 references indexed in Scilit:
- Monomeric Recombinant Peptide Aptamers Are Required for Efficient Intracellular Uptake and Target InhibitionMolecular Cancer Research, 2008
- rAAV vector-mediated gene therapy for experimental ischemic strokeNeurology India, 2008
- The Antimicrobial Peptide PR‐39 has a Protective Effect Against HeLa Cell ApoptosisChemical Biology & Drug Design, 2007
- Protection Against Myocardial Ischemia–Reperfusion Injury by the Angiogenic Masterswitch Protein PR 39 Gene Therapy: The Roles of HIF1α Stabilization and FGFR1 SignalingAntioxidants & Redox Signaling, 2007
- PR39 Inhibits Apoptosis in Hypoxic Endothelial CellsCirculation, 2004
- ThioredoxinCirculation Research, 2003
- Brain ischemia as a potential target of gene therapyExperimental Gerontology, 2003
- PR-39, a Syndecan-inducing Antimicrobial Peptide, Binds and Affects p130CasJournal of Biological Chemistry, 1998
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986